| Product NDC: | 0004-0256 |
| Proprietary Name: | Xenical |
| Non Proprietary Name: | orlistat |
| Active Ingredient(s): | 120 mg/1 & nbsp; orlistat |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0004-0256 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020766 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990423 |
| Package NDC: | 0004-0256-52 |
| Package Description: | 90 CAPSULE in 1 BOTTLE, PLASTIC (0004-0256-52) |
| NDC Code | 0004-0256-52 |
| Proprietary Name | Xenical |
| Package Description | 90 CAPSULE in 1 BOTTLE, PLASTIC (0004-0256-52) |
| Product NDC | 0004-0256 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | orlistat |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19990423 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | ORLISTAT |
| Strength Number | 120 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Intestinal Lipase Inhibitor [EPC],Lipase Inhibitors [MoA] |